A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains

Humanized mice are an invaluable tool for investigating human diseases such as cancer, infectious diseases, and graft-versus-host disease (GvHD). However, it is crucial to understand the strengths and limitations of humanized mice and select the most appropriate model. In this study, we describe the development of the human lymphoid and myeloid lineages using a flow cytometric analysis in four humanized mouse models derived from NOD mice xenotransplanted with CD34+ fetal cord blood from a single donor. Our results showed that all murine strains sustained human immune cells within a proinflammatory environment induced by GvHD. However, the Hu-SGM3 model consistently generated higher numbers of human T cells, monocytes, dendritic cells, mast cells, and megakaryocytes, and a low number of circulating platelets showing an activated profile when compared with the other murine strains. The hu-NOG-EXL model had a similar cell development profile but a higher number of circulating platelets with an inactivated state, and the hu-NSG and hu-NCG developed low frequencies of immune cells compared with the other models. Interestingly, only the hu-SGM3 and hu-EXL models developed mast cells. In conclusion, our findings highlight the importance of selecting the appropriate humanized mouse model for specific research questions, considering the strengths and limitations of each model and the immune cell populations of interest.

[1]  K. Ohlsen,et al.  Next-generation humanized NSG-SGM3 mice are highly susceptible to Staphylococcus aureus infection , 2023, Frontiers in Immunology.

[2]  S. Paust,et al.  Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection , 2023, Viruses.

[3]  C. Goldsmith,et al.  Teaching a new mouse old tricks: Humanized mice as an infection model for Variola virus , 2021, PLoS pathogens.

[4]  R. Zeiser,et al.  Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease , 2021, Frontiers in Immunology.

[5]  C. González-Espinosa,et al.  Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles , 2021, Frontiers in Immunology.

[6]  Todd M. Allen,et al.  Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection , 2021, Frontiers in Immunology.

[7]  G. Dai,et al.  Toward a humanized mouse model of Pneumocystis pneumonia , 2021, JCI insight.

[8]  Y. Fujisawa,et al.  Interferon-γ-stimulated apoptotic keratinocytes promote sclerodermatous changes in chronic graft-versus-host disease. , 2020, The Journal of investigative dermatology.

[9]  P. Hematti,et al.  Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source , 2020, Frontiers in Immunology.

[10]  C. Chen,et al.  Attenuated P. falciparum Parasite Shows Cytokine Variations in Humanized Mice , 2020, Frontiers in Immunology.

[11]  D. Weisdorf,et al.  Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality. , 2020, Blood advances.

[12]  P. Hematti,et al.  Early T Cell Activation Metrics Predict Graft-versus-Host Disease in a Humanized Mouse Model of Hematopoietic Stem Cell Transplantation , 2020, The Journal of Immunology.

[13]  K. Akashi,et al.  Establishment of a human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells. , 2020, Blood.

[14]  A. Ignatius,et al.  The Role of Mast Cells in Bone Metabolism and Bone Disorders , 2020, Frontiers in Immunology.

[15]  C. Qin,et al.  Xenotransplantation: Current Status in Preclinical Research , 2020, Frontiers in Immunology.

[16]  M. Rugeles,et al.  High activation and skewed T cell differentiation are associated with low IL‐17A levels in a hu‐PBL‐NSG‐SGM3 mouse model of HIV infection , 2020, Clinical and experimental immunology.

[17]  J. Chan,et al.  A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions , 2020, Journal of leukocyte biology.

[18]  M. Rugeles,et al.  Characterization of CXCR5+ CD8+ T-cells in humanized NSG mice. , 2019, Immunobiology.

[19]  R. P. Arya,et al.  Dengue viruses infect human megakaryocytes, with probable clinical consequences , 2019, PLoS neglected tropical diseases.

[20]  M. Tsuji,et al.  Functional Human CD141+ Dendritic Cells in Human Immune System Mice. , 2019, The Journal of infectious diseases.

[21]  A. Heredia,et al.  Suppression of Active HIV-1 Infection in CD34+ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs. , 2019, AIDS research and human retroviruses.

[22]  W. Robinson,et al.  IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis , 2019, eLife.

[23]  J. Bryant,et al.  HIV Replication in Humanized IL-3/GM-CSF-Transgenic NOG Mice , 2019, Pathogens.

[24]  T. L. Deans,et al.  High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow , 2019, Scientific Reports.

[25]  P. Tsapogas,et al.  Accumulation of Multipotent Hematopoietic Progenitors in Peripheral Lymphoid Organs of Mice Over-expressing Interleukin-7 and Flt3-Ligand , 2018, Front. Immunol..

[26]  T. D. de Gruijl,et al.  Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes , 2018, Front. Immunol..

[27]  M. Salazar,et al.  Dengue Virus Induces the Release of sCD40L and Changes in Levels of Membranal CD42b and CD40L Molecules in Human Platelets , 2018, Viruses.

[28]  T. Naoe,et al.  A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations. , 2018, Blood.

[29]  Joakim S. Dahlin,et al.  KIT signaling is dispensable for human mast cell progenitor development. , 2017, Blood.

[30]  Zhiqiang Zheng,et al.  Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model , 2017, PloS one.

[31]  S. Jonjić,et al.  Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand , 2016, PLoS pathogens.

[32]  L. Shultz,et al.  Improved B cell development in humanized NOD‐scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte‐macrophage colony‐stimulating factor and interleukin‐3 , 2016, Immunity, inflammation and disease.

[33]  C. O’Farrelly,et al.  Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain. , 2016, Stem cells and development.

[34]  D. Esterházy,et al.  Classical dendritic cells are required for dietary antigen-mediated peripheral regulatory T cell and tolerance induction , 2016, Nature Immunology.

[35]  A. Epstein,et al.  Influence of age, irradiation and humanization on NSG mouse phenotypes , 2015, Biology Open.

[36]  V. Kuchroo,et al.  Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. , 2015, The Journal of clinical investigation.

[37]  N. Cloonan,et al.  Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. , 2014, The Lancet. Oncology.

[38]  D. Cox,et al.  The Role of Platelets in the Pathogenesis of Viral Hemorrhagic Fevers , 2014, PLoS neglected tropical diseases.

[39]  Adam J. MacNeil,et al.  Stem cell factor induces AP‐1‐dependent mast cell IL‐6 production via MAPK kinase 3 activity , 2014, Journal of leukocyte biology.

[40]  T. Radstake,et al.  The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells. , 2014, Stem cells and development.

[41]  Zheng Zhang,et al.  Hepatitis B Virus Infection and Immunopathogenesis in a Humanized Mouse Model: Induction of Human-Specific Liver Fibrosis and M2-Like Macrophages , 2014, PLoS pathogens.

[42]  D. Gabrilovich,et al.  Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor , 2013, Immunology and cell biology.

[43]  H. Suemizu,et al.  Establishment of a Human Allergy Model Using Human IL-3/GM-CSF–Transgenic NOG Mice , 2013, The Journal of Immunology.

[44]  D. Hume,et al.  CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice. , 2013, Blood.

[45]  K. Akashi,et al.  Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment. , 2013, Blood.

[46]  Yong-Guang Yang,et al.  Full reconstitution of human platelets in humanized mice after macrophage depletion. , 2012, Blood.

[47]  M. Neurath,et al.  Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy. , 2012, Journal of Allergy and Clinical Immunology.

[48]  A. Murphy,et al.  Efficient differentiation and function of human macrophages in humanized CSF-1 mice. , 2011, Blood.

[49]  C. Rice,et al.  Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice. , 2011, Blood.

[50]  Satoshi Tanaka,et al.  Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice , 2010, Proceedings of the National Academy of Sciences.

[51]  W. Heath,et al.  The CD8+ dendritic cell subset , 2010, Immunological reviews.

[52]  C. Drake,et al.  STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model , 2009, The Journal of Immunology.

[53]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[54]  M. Manns,et al.  Humanized mice for modeling human infectious disease: challenges, progress, and outlook. , 2009, Cell host & microbe.

[55]  D. Greiner,et al.  Human peripheral blood leucocyte non‐obese diabetic‐severe combined immunodeficiency interleukin‐2 receptor gamma chain gene mouse model of xenogeneic graft‐versus‐host‐like disease and the role of host major histocompatibility complex , 2009, Clinical and experimental immunology.

[56]  Mamoru Ito,et al.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). , 2009, International immunology.

[57]  Christopher G. King,et al.  IL-17 contributes to CD4-mediated graft-versus-host disease. , 2009, Blood.

[58]  T. Suga,et al.  Interleukin-3 Does Not Affect the Differentiation of Mast Cells Derived from Human Bone Marrow Progenitors , 2008, Immunological investigations.

[59]  K. Akashi,et al.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice , 2005 .

[60]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[61]  P. Quesenberry,et al.  Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non‐obese diabetic–severe combined immunodeficient assay , 2001, British journal of haematology.

[62]  I. Weissman,et al.  Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor , 2000 .

[63]  B. Pulendran,et al.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. , 2000, Blood.

[64]  N. Van Rooijen,et al.  Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells. , 1998, Blood.

[65]  M. Tsai,et al.  Differential release of mast cell interleukin-6 via c-kit. , 1997, Blood.

[66]  E. Leiter,et al.  Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. , 1997, Journal of immunology.

[67]  H. Miyazaki,et al.  Thrombopoietin augments ex vivo expansion of human cord blood-derived hematopoietic progenitors in combination with stem cell factor and flt3 ligand , 1997, Leukemia.

[68]  J M Piret,et al.  Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin , 1996, The Journal of experimental medicine.

[69]  M. Brizzi,et al.  Effects of human FLT3 ligand on myeloid leukemia cell growth: heterogeneity in response and synergy with other hematopoietic growth factors. , 1995, Blood.

[70]  F. Alt,et al.  Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation , 1995, Cell.

[71]  E. Leiter,et al.  Genetic and pathogenic basis of autoimmune diabetes in NOD mice. , 1994, Current opinion in immunology.

[72]  M. Tsai,et al.  The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. , 1994, The American journal of pathology.

[73]  D. Metcalfe,et al.  Stem cell factor induces mast cell adhesion to fibronectin. , 1994, Journal of immunology.

[74]  C. Baker,et al.  Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci , 1992, Infection and immunity.

[75]  H. Gaskins,et al.  The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[76]  K. Zsebo,et al.  The c-kit receptor ligand functions as a mast cell chemoattractant. , 1992, Blood.

[77]  E. Thorsby,et al.  Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3. , 1991, Blood.

[78]  G. Bosma,et al.  The scid mouse mutant. , 1989, Current topics in microbiology and immunology.

[79]  H. Feldmann,et al.  Severity of Disease in Humanized Mice Infected With Ebola Virus or Reston Virus Is Associated With Magnitude of Early Viral Replication in Liver , 2017, The Journal of infectious diseases.

[80]  S. Heimfeld,et al.  Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. , 1993, Blood.

[81]  M. Pla,et al.  The Scid Mouse , 1989, Current Topics in Microbiology and Immunology.

[82]  M. Roussel,et al.  Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor. , 1988, Cold Spring Harbor symposia on quantitative biology.